ClimAIr: AI to Assess the Impact of Pollution and Climate on Respiratory Health in Europe

NCT07107009 · Status: NOT_YET_RECRUITING · Type: OBSERVATIONAL · Enrollment: 1906

Last updated 2025-12-17

No results posted yet for this study

Summary

The ClimAIr project will expand the evidence-based understanding of climate change, air pollution, and non-communicable respiratory diseases by using Artificial Intelligence (AI) tools. It will gather data on greenhouse gases levels and disaster risks, information on serious air pollutants and respiratory diseases' prevalence. The AI powered tools will be employed to generate better intervention methods and improve public health outcomes.

Federated Learning (FL) will be used to develop AI models to protect patients' privacy. By raising public awareness and delivering the ClimAIr tool - specifically designed to health workers, urban planners and policy makers - the project aims to influence policy decisions, promote healthier environments, and reduce respiratory diseases in Europe, which will be tested and validated the ClimAIr tool in specific municipalities that are part of the project. ClimAIr draws on a consortium of 21 partners from 15 European countries, including carefully selected health centres across Europe - in Spain, Luxembourg, Ukraine, Italy, France, Germany, Greece, Romania and Poland - focused on respiratory diseases, which will provide disease data and explore metabolic routes of the studied contaminants/diseases. ClimAIr is composed of an interdisciplinary team formed by research centres, ethical AI and modelling experts, SSH specialists, municipal governance, and a Communication \& Dissemination (C\&D) expert team dedicated to achieving and spread the results of the project.

Conditions

Sponsors & Collaborators

  • Theramed Healthcare SRL (Romania)

    collaborator UNKNOWN
  • Centre Hospitalier Universitaire de Toulouse, FRANCE

    collaborator UNKNOWN
  • Charite-Universitaetsmedizin Berlin (Germany)

    collaborator UNKNOWN
  • Aristotelio Panepistimio Thessalonikis (Greece)

    collaborator UNKNOWN
  • Uniwersytet Medyczny w Lodzi (Poland)

    collaborator UNKNOWN
  • Universita degli Studi di Milano (Italy)

    collaborator UNKNOWN
  • Bukovinian State Medical University (Ukraine)

    collaborator UNKNOWN
  • Luxembourg Institute of Health (Luxembourg)

    collaborator UNKNOWN
  • Andaluz Health Service

    collaborator OTHER_GOV
  • Fundación Pública Andaluza para la Investigación de Málaga en Biomedicina y Salud

    lead OTHER

Eligibility

Min Age
12 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2026-01-31
Primary Completion
2026-06-30
Completion
2027-12-31

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07107009 on ClinicalTrials.gov